This application is a National Stage Application of PCT/EP13/069957 under 35USC §371 (a), which claims priority of French Patent Application Serial No. 12/58965 filed Sep. 25, 2012, the disclosures of each of the above-identified applications are hereby incorporated by reference in their entirety.
1. Technical Field
The present invention relates to a method of preparing a haemostatic patch comprising a porous layer, for example a textile, based on oxidized cellulose and a film based on neutralized chitosan fixed on one of the faces of the porous layer.
2. Description of Related Art
Haemostatic patches are implantable medical devices for stopping the flow of biological fluids such as blood during surgery. For this purpose, they are generally composed of an absorbent porous layer, which is intended to trap the biological fluids, and a barrier known as a haemostatic barrier, which is intended to block the passage of the biological fluids.
Some haemostatic patches can be completely bioabsorbable, i.e. they are made to disappear in vivo after implantation, after a few weeks for example, when their function of stopping the effusion of biological fluids is no longer necessary.
Oxidized cellulose is of interest as a bioabsorbable material that can constitute the absorbent porous layer of a haemostatic patch: in fact, oxidized cellulose possesses intrinsic haemostatic properties.
Chitosan is a polysaccharide obtained by deacetylation of chitin. Chitin is one of the most widespread naturally occurring polysaccharides and is extracted from the exoskeletons of arthropods, from the endoskeletons of cephalopods as well as from fungi.
Chitosan has properties, such as biodegradability, bioabsorbability, biocompatibility, non-toxicity, and mechanical properties, that make it particularly interesting for medical applications. Thus, it would be interesting to combine a porous layer of oxidized cellulose with a film based on chitosan with a view to preparing a haemostatic patch. Chitosan in fact offers a good compromise, taking into account the properties that are required, for a haemostatic barrier, namely good biocompatibility and good mechanical properties.
However, chitosan is generally soluble in an acid environment. Thus, the films obtained from acid solutions based on chitosan are still highly laden with salts and still have their acid character. A chitosan film obtained from an acidic solution of chitosan can thus degrade and disintegrate when it is brought in contact with water or biological fluids. Therefore it can no longer perform its function of haemostatic barrier.
Accordingly, in order to be used in medical devices, especially in haemostatic patches, chitosan films must be neutralized. Generally this neutralization is obtained by treating these films with a strong base such as sodium hydroxide.
However, this treatment with sodium hydroxide can affect the integrity of the part of the patch supporting the chitosan film: thus, in the case of a haemostatic patch with an absorbent porous layer based on oxidized cellulose, treatment of the chitosan barrier film with sodium hydroxide would destroy the porous layer of oxidized cellulose.
Thus, it would be desirable to employ a method of preparing a haemostatic patch comprising a porous layer based on oxidized cellulose and a barrier film based on chitosan, which would avoid the phenomenon of degradation of the porous layer during the necessary neutralization of the chitosan film.
The present invention relates to a method of preparing a haemostatic patch comprising a porous layer based on oxidized cellulose and a neutralized film based on chitosan, said film comprising a free face and a face fixed on one of the faces of the porous layer, comprising the following steps:
the neutralizing step d°) comprises treatment of said film with a neutralizing composition comprising at least ethanol and ammonium hydroxide (NH4OH).
With the method according to the invention it is possible to obtain haemostatic patches based on a porous layer of oxidized cellulose and a chitosan barrier film without the risk of the chitosan film dissolving in contact with biological fluids, in particular in contact with blood. According to the method of the invention, firstly a film based on chitosan is manufactured starting from an acidic solution, then this film, alone or already fixed on the porous layer based on oxidized cellulose, is treated in order to neutralize it and obtain a final product usable in contact with biological fluids, without destroying the porous layer to which this film is attached. Regardless of the order of steps) c°) and d°) of the method according to the invention, the neutralizing composition of the method of the invention, comprising at least ethanol and ammonium hydroxide (NH4OH), makes it possible to neutralize the chitosan-based film without damaging the porous layer based on oxidized cellulose. In particular, neutralization by means of a neutralizing composition comprising at least ethanol and ammonium hydroxide (NH4OH) makes it possible to neutralize the chitosan-based film both at the surface and throughout its thickness, whether or not it is already fixed to the porous layer based on oxidized cellulose, without damaging said porous layer. With the method of the invention, it is possible to obtain a haemostatic patch having a film of neutralized chitosan as barrier, with a porous layer fixed to this film, said porous layer being based on oxidized cellulose, or said porous layer consisting of oxidized cellulose.
The present invention further relates to a haemostatic patch comprising a porous layer based on oxidized cellulose and a film based on chitosan fixed to one face of said porous layer, characterized in that said film is in neutralized form.
The present invention further relates to a haemostatic patch obtained by the method herein described, comprising a porous layer based on oxidized cellulose and a film based on chitosan fixed to one face of said porous layer, characterized in that said film is in neutralized form.
In one embodiment of the invention, the treatment in step d°) comprises a succession of operations of contacting at least the face that is free, or is intended to be free, of the film with said neutralizing composition. For example, if the film is fixed to the porous layer before it is neutralized, the treatment in step d°) will essentially consist of contacting only the free face of the film with the neutralizing composition, preferably without contacting the porous layer, on which the film will already be fixed: in fact, contact of the porous layer with the neutralizing composition could affect the integrity of the latter. Alternatively, if the film is neutralized before being fixed to the porous layer, the treatment in step d°) can comprise immersing the whole film, i.e. both of its faces, in a bath of the neutralizing composition. In both cases, the chitosan-based film is neutralized effectively at the surface and through its thickness, and the integrity of the porous layer is unaffected by the neutralizing composition comprising ethanol and ammonium hydroxide (NH4OH).
In one embodiment of the invention, step d°) further comprises a step of washing of said face of said film that is free, or intended to be free, after said treatment with the neutralizing composition. For example, the washing step comprises one or more operations of rinsing of at least said face of said film that is free, or intended to be free, with an ethanol/water composition followed by washing with water. Thus, if the film is fixed to the porous layer before it is neutralized, only its free face will be washed after application of the neutralizing composition. Alternatively, if the film is neutralized before being fixed on the porous layer, the whole film can be immersed in an ethanol/water composition and/or in water.
In one embodiment of the invention, the fixing step c°) is carried out before the neutralizing step d°). In such a case, for example, according to step b°), the acidic aqueous solution of chitosan is poured into a mould in the form of one or more layers, which are left to dry by evaporation of the water from said solution in order to obtain a film, then, according to step c°), before the end of the drying step of step b°), one face of the porous layer of oxidized cellulose is deposited on said film, complete drying of the film thus resulting in fixation of the porous layer on the film. In fact, when the porous layer is deposited on the film that is still in the course of drying, it penetrates superficially into the film under the action of the force of gravity. Thus, as drying is completed, the film traps the portion of the porous layer that has thus sunk slightly, thus providing fixation of the porous layer on the film. According to this embodiment of the invention, the treatment in step d°) comprises application of said neutralizing composition on the free face of the film, said neutralizing composition further comprising water. In such an embodiment of the invention, said neutralizing composition can for example consist of an ethanol/water/ammonium hydroxide mixture in the proportions 80/16/14 by weight. This formulation for the neutralizing composition of the method of the invention makes it possible to achieve effective neutralization of the film on its surface and through its thickness while avoiding causing shrinkage of the film, without damaging the integrity of the porous layer on which the film is already fixed.
In such an embodiment of the invention, for example, the neutralizing composition is applied on the free face of the film one or more times using a brush. For example, the bristles of a brush are soaked in neutralizing composition consisting of an ethanol/water/ammonium hydroxide mixture in the proportions 80/16/14 by weight and the free face of the film is brushed: several passes of the brush can be carried out, for example 3 passes. The film is thus neutralized. The film is then washed, as described above: for example, another brush is used, which is soaked with an ethanol/water composition, for example in the proportions 50/50 by weight. Several passes of the brush can be carried out, for example three. A last pass with a brush soaked in just water can be carried out to finalize the washing.
In another embodiment of the invention, the neutralizing step d°) is carried out before the fixing step c°). In such a case, for example, according to step b°), the acidic aqueous solution of chitosan is poured into a mould in the form of one or more layers, which are left to dry by evaporation of the water until a film is obtained, which is removed from the mould, then, according to step d°), the treatment of the film obtained in b°) comprises immersing said film in said neutralizing composition, preferably for 30 minutes. In such an embodiment, for example, once the film is completely dry and can be handled, it is immersed completely in a bath of neutralizing composition. Thus, in such a case, both faces of the film are treated with the neutralizing composition. In such an embodiment of the invention, the neutralizing composition can consist of an ethanol/ammonium hydroxide mixture in the proportions 80/20 by weight. This formulation for the neutralizing composition of the method of the invention makes it possible to carry out effective neutralization of the film without damaging the integrity of the porous layer when the film is to be fixed on the porous layer in the next step.
After immersion in a bath of the neutralizing composition as described above, the chitosan-based film is thus neutralized. The film can then be washed, as described above: for example, the film is immersed one or more times in baths of an ethanol/water composition, for example in the proportions 50/50 by weight, until a pH close to 7 is obtained for the washing baths. The film can then be submitted to a last bath of water only, to finalize the washing.
In such an embodiment, according to step c°), the neutralized film obtained at the end of step d°) can be fixed on one face of the porous layer of oxidized cellulose by means of a glue obtained starting from an acidic solution of chitosan. For example, said glue is spread on one face of the porous layer and/or on the face of the film intended to be fixed to the porous layer, and the film is fixed to the porous layer by application of the film on said face of the porous layer with pressure. The integrity of the porous layer based on oxidized cellulose is not affected during this fixing step.
Regardless of the order of steps c°) and d°) described above, a plasticizer, for example glycerol, can be added to the acidic aqueous solution of chitosan intended to form said chitosan-based film. With such an embodiment, a chitosan film can finally be obtained that has excellent mechanical properties.
In one embodiment of the invention, the porous layer is a textile, preferably a three-dimensional knitted fabric. Said porous layer, in the form of three-dimensional knitted fabric, gives excellent absorption of biological fluids, especially of blood.
The invention and its advantages will become clearer from the following detailed description and the drawings in which:
According to a first step of the method according to the invention, step a°), a porous layer based on oxidized cellulose is provided. “Based on oxidized cellulose” means, according to the present application, that the main component of the porous layer is oxidized cellulose. The porous layer can further comprise other biocompatible, preferably bioabsorbable, materials. For example, the porous layer can comprise, as other bioabsorbable materials, synthetic polymers such as polylactic acid and/or polymers of natural origin such as chitosan.
Oxidized cellulose is a known bioabsorbable material. It can for example be selected from oxidized cellulose, where the C6 primary alcohol is partially or fully oxidized to carboxylic acid, for example to give polyglucuronic acid, oxidized cellulose in the form of polyaldehydes by periodic acid, and mixtures thereof. The cellulose used for oxidation can be obtained from type I cellulose or can be regenerated.
Several types of regenerated cellulose have been developed industrially. We may mention for example the “viscose” process, which is based on the solubility of cellulose xanthate in a dilute solution of sodium hydroxide. We may also mention the so-called “cupro-ammonium process” employed for example by the company Bemberg in Italy or the company Asahi Chemical Industries in Japan, which consists of dissolving cellulose in an ammoniacal solution of copper. Another method of preparing regenerated cellulose suitable for the present invention is the method of organic-phase dissolution of cellulose by N-methylmorpholine oxide (N.M.M.O.), called the “Lyocell® process”, employed for example by the company Lenzing in Austria.
In the present application, “porous layer” means a layer having pores, or voids, cells, holes, orifices, distributed regularly or irregularly, not only on the surface but also within the thickness of said layer, and more or less interconnected. Said porous layer is particularly effective for absorbing biological fluids such as blood.
In one embodiment, the porous layer based on oxidized cellulose is in the form of a textile openwork based on oxidized cellulose.
According to the present application, “textile” means any arrangement or assemblage of biocompatible threads, fibres, filaments and/or multifilaments, for example obtained by knitting, weaving, braiding, or alternatively non-woven. The arrangement of threads of the textile according to the invention defines at least two opposite faces, a first face and a second face.
In the present application, “textile openwork” means any textile whose arrangement of threads of which it is constituted determines openings, cells or voids in the thickness of the textile and on the faces of the textile, and these openings, cells or voids can constitute channels with openings on either side of the textile. This textile openwork gives good absorption of biological fluids.
The textile can be in the form of a two-dimensional or three-dimensional knitted fabric.
“Two-dimensional knitted fabric” means, in the sense of the present application, a knitted fabric having two opposite faces joined together by stitches but lacking cross-members giving it a certain thickness: a knitted fabric of this kind can be obtained for example by knitting threads on a warp knitting machine or Raschel machine using two guide bars. Examples of knitting of two-dimensional knitted fabrics suitable for the present invention are given in document WO2009/071998.
“Three-dimensional knitted fabric” means, according to the present application, a knitted fabric having two opposite faces joined together by a cross-member giving the knitted fabric a significant thickness, said cross-member itself being formed of additional connecting threads supplementary to the threads forming the two faces of the knitted fabric. This knitted fabric can be obtained for example on a warp knitting machine or double-bed Raschel machine using several guide bars. Examples of knitting of three-dimensional knitted fabrics suitable for the present invention are given in documents WO99/05990, WO2009/031035, WO2009/071998.
This kind of three-dimensional knitted fabric, with the presence of a cross-member giving it a significant thickness, provides excellent absorption of biological fluids such as blood and is particularly suitable for manufacture of the haemostatic patch of the invention.
A knitted fabric, in particular three-dimensional, based on oxidized cellulose, can be obtained by knitting firstly threads of unoxidized regenerated cellulose, then submitting the knitted fabric thus obtained to oxidation.
In fact, when spun through a perforated plate, viscose sets in an acid medium and forms long continuous filaments of regenerated cellulose, which are dried and combined in multifilament threads. A regenerated cellulose thread is obtained that has good mechanical strength.
Generally this regenerated cellulose thread is not absorbable. However, it has good mechanical strength allowing it to be used for manufacturing a knitted fabric. As an example, we may mention, as regenerated cellulose thread suitable for manufacturing a knitted fabric suitable for the porous layer of the patch of the invention, the 90 decitex multifilament thread marketed under the name “CUPRO® Cusio” by the Italian company Bemberg.
The knitted fabric obtained is then oxidized in order to form a porous layer based on oxidized cellulose suitable for the haemostatic patch and for the method of preparing said patch according to the present invention.
In a preferred embodiment of the method of the invention, the porous layer based on oxidized cellulose is a three-dimensional knitted fabric made from oxidized cellulose.
According to a second step of the method according to the invention, step b), a film based on chitosan is prepared starting from an acidic aqueous solution of chitosan.
“Based on chitosan” means, according to the present application, that the main component of the film is chitosan. The chitosan-based film can further comprise other compounds. For example, the chitosan-based film can comprise a plasticizer, for example glycerol, to improve the mechanical properties of the film.
Chitosan is a biocompatible biopolymer obtained by deacetylation of chitin. Chitin is extracted from exoskeletons of arthropods such as the lobster, crab, prawn, the endoskeleton of cephalopods such as the squid, or from fungi. Extraction of chitin involves steps of hydrolysis of the proteins and lipids, depigmentation and demineralization. Hydrolysis of the proteins and lipids is usually carried out in the presence of sodium hydroxide, and demineralization requires the use of hydrochloric acid.
Once the chitin has been extracted, chitosan is obtained by a deacetylation step, which consists of hydrolysis of the acetamide groups. This reaction is generally carried out at high temperature in an alkaline solution, for example a 48% solution of sodium hydroxide (NaOH) in water, at 90° C. Chitosan is a compound that is soluble in aqueous solution and can have a degree of acetylation (DA) of up to 70%.
The following publications describe processes for deacetylation of chitin to obtain chitosan: “Lamarque, G., C. Viton, and A. Domard, New Route of Deacetylation of α- and β-Chitins by means of Freeze-Pump Out-Thaw Cycles. Biomacromolecules, 2005. 6 (3): p. 1380-1388.”, “Lamarque, G., C. Viton, and A. Domard, Comparative Study of the First Heterogeneous Deacetylation of α- and β-Chitins in a Multistep Process. Biomacromolecules, 2004. 5 (3): p. 992-1001.”, “Lamarque, G., C. Viton, and A. Domard, Comparative Study of the Second and Third Heterogeneous Deacetylations of α- and β-Chitins in a Multistep Process. Biomacromolecules, 2004. 5 (5): p. 1899-1907.”, “Tolaimate, A., et al., Contribution to the preparation of chitins and chitosans with controlled physicochemical properties. Polymer, 2003. 44 (26): p. 7939-7952.”
Chitosan is a bioabsorbable compound. The degree of acetylation of chitosan can have an influence on the kinetics of degradation of chitosan. Thus, depending on the kinetics of biodegradation desired for the film of the haemostatic patch prepared according to the method of the invention, the chitosan will have to have a degree of acetylation of 2, 10, 20, 30, 40, 50, 60 or 70%.
In one embodiment of the method according to the invention, the degree of acetylation of the chitosan ranges from 2 to 70%. With this chitosan it is possible to obtain a film having optimum degradation kinetics for the manufacture of haemostatic patches.
The chitosan solution in step b) of the method according to the invention is generally prepared starting from a solution of chitosan in water, with the concentration of chitosan in said solution ranging for example from 0.25% to 10%, by weight, relative to the total weight of the solution, to which an acid is added in stoichiometric proportion, said acid being selected for example from acetic acid, hydrochloric acid and mixtures thereof. For a chitosan of molecular weight 500 000 Da (500 000 g/mol), for example, the concentration of chitosan in the starting aqueous solution can range from 0.25% to 5%, by weight, relative to the total weight of the solution.
With these chitosan concentrations it is possible to obtain, finally, a film that has good mechanical properties.
In one embodiment of the method according to the invention, the pH of the acidic aqueous solution of chitosan is from 2.5 to 5.5.
In order to form the chitosan-based film of the method of the invention, the acidic aqueous solution of chitosan is poured into a mould in order to form a layer. The acidic aqueous solution can be cast in the mould in the form of one or more layers, depending on the final thickness that is desired for the barrier film of the haemostatic patch. Generally, the mould is of rectangular shape having dimensions compatible with the use of the film obtained as part of a haemostatic patch.
The layer or layers of acidic aqueous solution are left to dry for evaporation of the water present in the acidic aqueous starting solution. Generally this drying step is carried out under a laminar-flow hood.
Drying of the layer or layers of acidic aqueous solution by evaporation of the water as stated above will make it possible to obtain the chitosan-based film used in the method according to the invention.
During step b°) of formation of the chitosan-based film, the water of the acidic aqueous starting solution is evaporated but the acid remains in the film. The film obtained is therefore of an acidic character. This film cannot be used as it is for forming the barrier of the haemostatic patch of the invention, as it would disintegrate very rapidly merely in contact with biological fluids.
Thus, besides a step of fixing the film to the porous layer based on oxidized cellulose, the method according to the invention comprises a step of neutralizing the film obtained in b°), and this neutralizing step can be carried out before or after the fixing step.
In the rest of the description, a first embodiment of the method according to the invention will be described first, according to which, firstly, the film is fixed to the porous layer based on oxidized cellulose, then it is neutralized, while it is already fixed on the porous layer based on oxidized cellulose. A second embodiment of the method according to the invention will then be described, according to which the film is neutralized first, then it is fixed to the porous layer based on oxidized cellulose.
According to the first embodiment of the method according to the invention, before the end of the drying step in step b°) of formation of the film, the porous layer of oxidized cellulose, in particular the three-dimensional knitted fabric, is deposited on the last layer of acidic aqueous solution based on chitosan that is cast. Under the action of gravity, the porous layer, for example the three-dimensional knitted fabric, penetrates superficially within the last layer cast that is drying. In final drying by evaporation of the water that remains in the last layer cast, the film traps the portion of the porous layer, for example of the three-dimensional knitted fabric, that had slightly penetrated into said last layer cast, and the porous layer is thus fixed to the film.
In the case when the film is fixed to the porous layer before it is neutralized, the neutralizing treatment is carried out on the face of the film that has been left free, i.e. on the face of the film that is not attached to the porous layer, in particular to the textile or knitted fabric based on oxidized cellulose.
In this first embodiment of the invention, for example, the neutralizing composition is applied on the free face of the film one or more times with a brush, taking care that the neutralizing composition does not come in contact with the porous layer based on oxidized cellulose. For example, the bristles of a brush are soaked with neutralizing composition consisting of an ethanol/water/ammonium hydroxide mixture in the proportions 80/16/14 by weight and the free face of the film is brushed or painted: several passes of the brush can be carried out, for example 3 passes. This formulation for the neutralizing composition makes it possible to avoid shrinkage of the film during this neutralizing step. Moreover, said formulation for the neutralizing composition and said number of passes make it possible to carry out effective neutralization of the chitosan-based film, both at the surface and throughout its thickness, without damaging the integrity of the porous layer on which the film is already fixed. The film thus loses its acid character and is neutralized.
The film can then be washed: for example, another brush is used, which is soaked with an ethanol/water composition, for example in the proportions 50/50 by weight, and which is brushed over the free face of the film, still without contacting the porous layer, for example the three-dimensional knitted fabric, based on oxidized cellulose. Several passes of the brush can be carried out, for example three, or up to five. A last pass with a brush soaked in water only can be carried out to finalize the washing.
According to the second embodiment of the method according to the invention, the cast layers of acidic aqueous solution from step b°) of formation of the thread are left to dry by complete evaporation of the water and until a film is obtained that can easily be removed from the mould and handled.
The chitosan-based film thus obtained, which has not been neutralized, can be submitted to one or more operations of immersion in baths of said neutralizing composition. For example, the film can be immersed in a bath of neutralizing composition preferably for 30 minutes. Thus, in this second embodiment of the method according to the invention, both faces of the chitosan-based film are treated with the neutralizing composition. In such an embodiment of the invention, the neutralizing composition can consist of an ethanol/ammonium hydroxide mixture in the proportions 80/20 by weight. This formulation for the neutralizing composition of the method of the invention makes it possible to carry out effective neutralization of the film, both on the surface of the film and in its thickness, without damaging the integrity of the porous layer during the next step of fixation of the film on the porous layer based on oxidized cellulose.
After immersion in a bath of the neutralizing composition as described above, the chitosan-based film has lost its acid character and it is neutralized. The film can then be washed: for example, the film is immersed one or more times in baths of an ethanol/water composition, for example in the proportions 50/50 by weight, until a pH close to 7 is obtained for the washing baths. The film can then be submitted to a last bath of water only to finalize the washing.
In this second embodiment, according to step c°), the neutralized film obtained at the end of step d°) can be fixed on one face of the porous layer of oxidized cellulose, for example on the three-dimensional knitted fabric, by means of a glue obtained starting from an acidic solution of chitosan. For example, said glue is spread on one face of the porous layer and/or on the face of the film intended to be fixed to the porous layer, and the film is fixed to the porous layer by application of the film on said face of the porous layer with pressure. The integrity of the porous layer based on oxidized cellulose is not affected during this fixing step.
Regardless of which embodiment described above is used, a patch is obtained comprising a porous layer based on oxidized cellulose, for example a three-dimensional knitted fabric, and a film based on chitosan fixed to one face of this porous layer, the film being in neutralized form. This patch can be used effectively as a haemostatic patch for stopping effusion of blood during a surgical operation. Moreover, this patch can be completely bioabsorbable: it can thus disappear in the weeks following its implantation, for example in less than 4 weeks, once its haemostatic function is no longer required. This thus avoids introducing a foreign body into a patient's body permanently.
The fixation of a film based on neutralized chitosan on a textile of oxidized cellulose is described in the present example, referring to
A textile of oxidized cellulose 1, which is a porous three-dimensional knitted fabric, as shown in
An acidic solution based on chitosan is prepared by adding acetic acid in stoichiometric proportions to a solution of chitosan with a degree of acetylation of 50% and with a molecular weight of 550 000 Da at 10 wt % in water. 25 wt % of glycerol is added. The presence of glycerol in the acidic starting solution of chitosan then makes it possible to obtain a film that has good mechanical properties.
The acidic solution thus obtained 2 is poured into a rectangular mould 3 as shown in
The solution can be cast in the mould in the form of several successive layers so that a thicker film is finally obtained. For example, three successive layers of acidic solution can be cast.
Before drying the last layer cast of the acidic solution 2, one face of the textile of oxidized cellulose 1, cut to the dimensions of the mould, is deposited on this layer as shown in
A neutralizing composition is prepared, consisting of an ethanol/water/ammonium hydroxide mixture in the proportions 80/16/14 by weight. A brush 5 is soaked with this neutralizing composition and is applied on the free face of the chitosan film 4, i.e. on the face of the chitosan film which is not attached to the textile of oxidized cellulose 1, as shown in
During said application, care is taken not to bring the textile of oxidized cellulose 1 into contact with the neutralizing composition.
The neutralizing composition is applied on said face of the film at least three times. This formulation for the neutralizing composition makes it possible to avoid shrinkage of the film during this neutralizing step.
The neutralization is effective: the film can then be washed with aqueous solutions without risk of redissolving.
Thus, the neutralized film is rinsed by application of a brush soaked in an ethanol/water mixture in proportions of 50/50 by weight. This mixture can be applied several times, preferably up to three times. The film is then washed with water (100% water), either by application of a brush soaked with water, or by immersing in a water bath.
We thus obtain a textile of oxidized cellulose with a chitosan film fixed on one of its faces, said film having been neutralized. With the method of the invention, the textile of oxidized cellulose has not been damaged by the step of neutralization of the chitosan film and this textile has preserved its integrity. Moreover, the chitosan-based film has kept its initial dimensions, even after neutralization.
The textile thus obtained, with one of its faces covered with a film of neutralized chitosan, can be used as haemostatic patch 6 and can be implanted in a human body without risk of the chitosan film disintegrating and disappearing in contact with biological fluids.
The textile part, which is a three-dimensional knitted fabric of oxidized cellulose 1, thus forms a porous layer capable of absorbing blood. The film of neutralized chitosan, for its part, does not degrade in contact with biological fluids, and it acts as a haemostatic barrier.
The whole patch 6, namely the textile part and the film, is bioabsorbable and disappears in less than 4 weeks after implantation.
Said patch 6 is particularly useful for stopping effusions of blood during surgery. Said patch is completely bioabsorbable and disappears in less than 4 weeks after implantation, when its haemostatic function is no longer required.
The fixation of a film based on neutralized chitosan to a textile of oxidized cellulose is described in the present example, referring to
An acidic solution based on chitosan is prepared by adding acetic acid in stoichiometric proportions to a solution of chitosan with a degree of acetylation of 50% and a molecular weight of 550 000 Da at 10 wt % in water. 25 wt % of glycerol is added. The presence of glycerol in the acidic starting solution of chitosan then makes it possible to obtain a film that has good mechanical properties.
The acidic solution 2 thus obtained is poured into a rectangular mould 3 as shown in
The solution can be cast in the mould in the form of several successive layers so that a thicker film is finally obtained. For example, three successive layers of acidic solution are cast.
The layers are left to dry until the water has evaporated completely and a dry film 4 is obtained (
The chitosan film 4 obtained is of an acid character and has not been neutralized. In order to neutralize it, it is immersed in a neutralizing composition 5 consisting of an ethanol/ammonium hydroxide mixture in the proportions 80/20 by weight: for example, film 4 is immersed in said composition for 30 minutes in an orbital stirrer 6, as shown in
The neutralization is effective: the film can then be washed in aqueous solutions without risk of redissolving.
Thus, the neutralized film is rinsed by successive operations of immersion, for example three times, in baths of an ethanol/water mixture in proportions of 50/50 by weight until a pH of 7 is obtained for the rinsing mixture. The film is then washed by immersing in a water bath (100% water).
The film is then left to dry in spread-out form to avoid the formation of creases in the film.
The film of neutralized chitosan thus obtained 7 is then fixed on one face of a textile of oxidized cellulose by means of a glue based on chitosan as explained below, referring to
To prepare the glue, acetic acid is added in stoichiometric proportions to a solution of chitosan with a degree of acetylation of 50% and a molecular weight of 550 000 Da at 10 wt % in water.
The glue obtained 8 is spread on one face of the film of neutralized chitosan 7 as shown in
A textile of oxidized cellulose 9 is provided, which is a porous three-dimensional knitted fabric as shown in
The textile of oxidized cellulose 9 is applied with pressure on the glue 8, as shown in
The “textile+film” assembly can then be dried under a laminar-flow hood.
A textile of oxidized cellulose is thus obtained with a chitosan film fixed on one of its faces, said film having been neutralized. With the method of the invention, the textile of oxidized cellulose has not been damaged by the step of neutralization of the chitosan film and this textile has preserved its integrity. Moreover, the chitosan-based film has a good, smooth and crease-free appearance.
The textile thus obtained, with one of its faces covered with a film of neutralized chitosan, can be used as haemostatic patch 10 and can be implanted in a human body without risk of the chitosan film 7 disintegrating and disappearing in contact with biological fluids.
The textile part, which is a three-dimensional knitted fabric of oxidized cellulose, thus forms a porous layer capable of absorbing blood. The film of neutralized chitosan, for its part, does not degrade in contact with biological fluids, and it acts as a haemostatic barrier.
The whole of patch 10, namely the textile part and the film, is bioabsorbable and disappears in less than 4 weeks after implantation.
Said patch 10 is particularly useful for stopping effusions of blood during surgery. This patch is completely bioabsorbable and disappears in less than four weeks after implantation, when its haemostatic function is no longer required.
Number | Date | Country | Kind |
---|---|---|---|
12 58965 | Sep 2012 | FR | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/EP2013/069957 | 9/25/2013 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2014/048982 | 4/3/2014 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1187158 | Mcginley | Jun 1916 | A |
3054406 | Usher | Sep 1962 | A |
3118294 | Van Laethem | Jan 1964 | A |
3124136 | Usher | Mar 1964 | A |
3272204 | Charles et al. | Sep 1966 | A |
3276448 | Usher | Oct 1966 | A |
3320649 | Naimer | May 1967 | A |
3364200 | Ashton et al. | Jan 1968 | A |
3570482 | Emoto et al. | Mar 1971 | A |
3718725 | Hamano | Feb 1973 | A |
4006747 | Kronenthal et al. | Feb 1977 | A |
4060081 | Yannas et al. | Nov 1977 | A |
4173131 | Pendergrass et al. | Nov 1979 | A |
4193137 | Heck | Mar 1980 | A |
4248064 | Odham | Feb 1981 | A |
4294241 | Miyata | Oct 1981 | A |
4307717 | Hymes et al. | Dec 1981 | A |
4338800 | Matsuda | Jul 1982 | A |
4476697 | Schafer et al. | Oct 1984 | A |
4487865 | Balazs et al. | Dec 1984 | A |
4500676 | Balazs et al. | Feb 1985 | A |
4511653 | Play et al. | Apr 1985 | A |
4527404 | Nakagaki et al. | Jul 1985 | A |
4591501 | Cioca | May 1986 | A |
4597762 | Walter et al. | Jul 1986 | A |
4603695 | Ikada et al. | Aug 1986 | A |
4631932 | Sommers | Dec 1986 | A |
4670014 | Huc et al. | Jun 1987 | A |
4709562 | Matsuda | Dec 1987 | A |
4748078 | Doi et al. | May 1988 | A |
4759354 | Quarfoot | Jul 1988 | A |
4769038 | Bendavid et al. | Sep 1988 | A |
4796603 | Dahlke et al. | Jan 1989 | A |
4813942 | Alvarez | Mar 1989 | A |
4841962 | Berg et al. | Jun 1989 | A |
4854316 | Davis | Aug 1989 | A |
4925294 | Geshwind et al. | May 1990 | A |
4931546 | Tardy et al. | Jun 1990 | A |
4942875 | Hlavacek et al. | Jul 1990 | A |
4948540 | Nigam | Aug 1990 | A |
4950483 | Ksander et al. | Aug 1990 | A |
4970298 | Silver et al. | Nov 1990 | A |
4976737 | Leake | Dec 1990 | A |
5002551 | Linsky et al. | Mar 1991 | A |
5015584 | Brysk | May 1991 | A |
5116357 | Eberbach | May 1992 | A |
5147374 | Fernandez | Sep 1992 | A |
5162430 | Rhee et al. | Nov 1992 | A |
5171273 | Silver et al. | Dec 1992 | A |
5176692 | Wilk et al. | Jan 1993 | A |
5192301 | Kamiya et al. | Mar 1993 | A |
5195542 | Gazielly et al. | Mar 1993 | A |
5196185 | Silver et al. | Mar 1993 | A |
5201745 | Tayot et al. | Apr 1993 | A |
5201764 | Kelman et al. | Apr 1993 | A |
5206028 | Li | Apr 1993 | A |
5217493 | Raad et al. | Jun 1993 | A |
5254133 | Seid | Oct 1993 | A |
5256418 | Kemp et al. | Oct 1993 | A |
5258000 | Gianturco | Nov 1993 | A |
5263983 | Yoshizato et al. | Nov 1993 | A |
5304595 | Rhee et al. | Apr 1994 | A |
5306500 | Rhee et al. | Apr 1994 | A |
5308663 | Nakagawa | May 1994 | A |
5324775 | Rhee et al. | Jun 1994 | A |
5328955 | Rhee et al. | Jul 1994 | A |
5334527 | Brysk | Aug 1994 | A |
5339657 | McMurray | Aug 1994 | A |
5350583 | Yoshizato et al. | Sep 1994 | A |
5356432 | Rutkow et al. | Oct 1994 | A |
5368549 | McVicker | Nov 1994 | A |
5368602 | de la Torre | Nov 1994 | A |
5370650 | Tovey et al. | Dec 1994 | A |
5376375 | Rhee et al. | Dec 1994 | A |
5376376 | Li | Dec 1994 | A |
5397331 | Himpens et al. | Mar 1995 | A |
5399361 | Song et al. | Mar 1995 | A |
5413791 | Rhee et al. | May 1995 | A |
5425740 | Hutchinson, Jr. | Jun 1995 | A |
5428022 | Palefsky et al. | Jun 1995 | A |
5433996 | Kranzler et al. | Jul 1995 | A |
5441491 | Verschoor et al. | Aug 1995 | A |
5441508 | Gazielly et al. | Aug 1995 | A |
5456693 | Conston et al. | Oct 1995 | A |
5456711 | Hudson | Oct 1995 | A |
5466462 | Rosenthal et al. | Nov 1995 | A |
5480644 | Freed | Jan 1996 | A |
5487895 | Dapper et al. | Jan 1996 | A |
5490984 | Freed | Feb 1996 | A |
5512291 | Li | Apr 1996 | A |
5512301 | Song et al. | Apr 1996 | A |
5514181 | Light et al. | May 1996 | A |
5522840 | Krajicek | Jun 1996 | A |
5523348 | Rhee et al. | Jun 1996 | A |
5536656 | Kemp et al. | Jul 1996 | A |
5543441 | Rhee et al. | Aug 1996 | A |
5565210 | Rosenthal et al. | Oct 1996 | A |
5567806 | Abdul-Malak et al. | Oct 1996 | A |
5569273 | Titone et al. | Oct 1996 | A |
RE35399 | Eisenberg | Dec 1996 | E |
5593441 | Lichtenstein et al. | Jan 1997 | A |
5595621 | Light et al. | Jan 1997 | A |
5601571 | Moss | Feb 1997 | A |
5607474 | Athanasiou et al. | Mar 1997 | A |
5607590 | Shimizu | Mar 1997 | A |
5614587 | Rhee et al. | Mar 1997 | A |
5618551 | Tardy et al. | Apr 1997 | A |
5634931 | Kugel | Jun 1997 | A |
5639796 | Lee | Jun 1997 | A |
5665391 | Lea | Sep 1997 | A |
5667839 | Berg | Sep 1997 | A |
5676967 | Williams et al. | Oct 1997 | A |
5681568 | Goldin et al. | Oct 1997 | A |
5686090 | Schilder et al. | Nov 1997 | A |
5686115 | Vournakis et al. | Nov 1997 | A |
5690675 | Sawyer et al. | Nov 1997 | A |
5695525 | Mulhauser et al. | Dec 1997 | A |
5697978 | Sgro | Dec 1997 | A |
5700476 | Rosenthal et al. | Dec 1997 | A |
5700477 | Rosenthal et al. | Dec 1997 | A |
5702416 | Kieturakis et al. | Dec 1997 | A |
5709934 | Bell et al. | Jan 1998 | A |
5711960 | Shikinami | Jan 1998 | A |
5716409 | Debbas | Feb 1998 | A |
5720981 | Eisinger | Feb 1998 | A |
5732572 | Litton | Mar 1998 | A |
5743917 | Saxon | Apr 1998 | A |
5749895 | Sawyer et al. | May 1998 | A |
5752974 | Rhee et al. | May 1998 | A |
5756111 | Yoshikawa | May 1998 | A |
5766246 | Mulhauser et al. | Jun 1998 | A |
5766631 | Arnold | Jun 1998 | A |
5769864 | Kugel | Jun 1998 | A |
5771716 | Schlussel | Jun 1998 | A |
5785983 | Furlan et al. | Jul 1998 | A |
5800541 | Rhee et al. | Sep 1998 | A |
5814328 | Gunasekaran | Sep 1998 | A |
5833705 | Ken et al. | Nov 1998 | A |
5840011 | Landgrebe et al. | Nov 1998 | A |
5861034 | Taira et al. | Jan 1999 | A |
5863984 | Doillon et al. | Jan 1999 | A |
5869080 | McGregor et al. | Feb 1999 | A |
5871767 | Dionne et al. | Feb 1999 | A |
5876444 | Lai | Mar 1999 | A |
5891558 | Bell et al. | Apr 1999 | A |
5899909 | Claren et al. | May 1999 | A |
5900479 | Glasser | May 1999 | A |
5906937 | Sugiyama et al. | May 1999 | A |
5910149 | Kuzmak | Jun 1999 | A |
5911731 | Pham et al. | Jun 1999 | A |
5916225 | Kugel | Jun 1999 | A |
5919232 | Chaffringeon et al. | Jul 1999 | A |
5919233 | Knopf et al. | Jul 1999 | A |
5922026 | Chin | Jul 1999 | A |
5931165 | Reich et al. | Aug 1999 | A |
5942278 | Hagedorn et al. | Aug 1999 | A |
5962136 | Dewez et al. | Oct 1999 | A |
5972022 | Huxel | Oct 1999 | A |
RE36370 | Li | Nov 1999 | E |
5993844 | Abraham et al. | Nov 1999 | A |
5994325 | Roufa et al. | Nov 1999 | A |
5997895 | Narotam et al. | Dec 1999 | A |
6001895 | Harvey et al. | Dec 1999 | A |
6008292 | Lee et al. | Dec 1999 | A |
6015844 | Harvey et al. | Jan 2000 | A |
6039686 | Kovac | Mar 2000 | A |
6042534 | Gellman et al. | Mar 2000 | A |
6042592 | Schmitt | Mar 2000 | A |
6043089 | Sugiyama et al. | Mar 2000 | A |
6051425 | Morota et al. | Apr 2000 | A |
6056688 | Benderev et al. | May 2000 | A |
6056970 | Greenawalt et al. | May 2000 | A |
6057148 | Sugiyama et al. | May 2000 | A |
6063396 | Kelleher | May 2000 | A |
6066776 | Goodwin et al. | May 2000 | A |
6066777 | Benchetrit | May 2000 | A |
6071292 | Makower et al. | Jun 2000 | A |
6077281 | Das | Jun 2000 | A |
6080194 | Pachence et al. | Jun 2000 | A |
6083522 | Chu et al. | Jul 2000 | A |
6090116 | D'Aversa et al. | Jul 2000 | A |
6113623 | Sgro | Sep 2000 | A |
6120539 | Eldridge et al. | Sep 2000 | A |
6132765 | DiCosmo et al. | Oct 2000 | A |
6143037 | Goldstein et al. | Nov 2000 | A |
6153292 | Bell et al. | Nov 2000 | A |
6162962 | Hinsch et al. | Dec 2000 | A |
6165488 | Tardy et al. | Dec 2000 | A |
6171318 | Kugel et al. | Jan 2001 | B1 |
6174320 | Kugel et al. | Jan 2001 | B1 |
6176863 | Kugel et al. | Jan 2001 | B1 |
6179872 | Bell et al. | Jan 2001 | B1 |
6180848 | Flament et al. | Jan 2001 | B1 |
6197325 | MacPhee et al. | Mar 2001 | B1 |
6197934 | DeVore et al. | Mar 2001 | B1 |
6197935 | Doillon et al. | Mar 2001 | B1 |
6210439 | Firmin et al. | Apr 2001 | B1 |
6214020 | Mulhauser et al. | Apr 2001 | B1 |
6221109 | Geistlich et al. | Apr 2001 | B1 |
6224616 | Kugel | May 2001 | B1 |
6241768 | Agarwal et al. | Jun 2001 | B1 |
6258124 | Darois et al. | Jul 2001 | B1 |
6262332 | Ketharanathan | Jul 2001 | B1 |
6264702 | Ory et al. | Jul 2001 | B1 |
6267772 | Mulhauser et al. | Jul 2001 | B1 |
6270530 | Eldridge et al. | Aug 2001 | B1 |
6277397 | Shimizu | Aug 2001 | B1 |
6280453 | Kugel et al. | Aug 2001 | B1 |
6287316 | Agarwal et al. | Sep 2001 | B1 |
6290708 | Kugel et al. | Sep 2001 | B1 |
6306079 | Trabucco | Oct 2001 | B1 |
6306424 | Vyakarnam et al. | Oct 2001 | B1 |
6312474 | Francis et al. | Nov 2001 | B1 |
6319264 | Tormala et al. | Nov 2001 | B1 |
6328686 | Kovac | Dec 2001 | B1 |
6334872 | Termin et al. | Jan 2002 | B1 |
6383201 | Dong | May 2002 | B1 |
6391060 | Ory et al. | May 2002 | B1 |
6391333 | Li et al. | May 2002 | B1 |
6391939 | Tayot et al. | May 2002 | B2 |
6408656 | Ory et al. | Jun 2002 | B1 |
6410044 | Chudzik et al. | Jun 2002 | B1 |
6413742 | Olsen et al. | Jul 2002 | B1 |
6425924 | Rousseau | Jul 2002 | B1 |
6428978 | Olsen et al. | Aug 2002 | B1 |
6436030 | Rehil | Aug 2002 | B2 |
6440167 | Shimizu | Aug 2002 | B2 |
6443964 | Ory et al. | Sep 2002 | B1 |
6447551 | Goldmann | Sep 2002 | B1 |
6447802 | Sessions et al. | Sep 2002 | B2 |
6448378 | DeVore et al. | Sep 2002 | B2 |
6451032 | Ory et al. | Sep 2002 | B1 |
6451301 | Sessions et al. | Sep 2002 | B1 |
6454787 | Maddalo et al. | Sep 2002 | B1 |
6477865 | Matsumoto | Nov 2002 | B1 |
6479072 | Morgan et al. | Nov 2002 | B1 |
6485503 | Jacobs et al. | Nov 2002 | B2 |
6500464 | Ceres et al. | Dec 2002 | B2 |
6500777 | Wiseman et al. | Dec 2002 | B1 |
6509031 | Miller et al. | Jan 2003 | B1 |
6511958 | Atkinson et al. | Jan 2003 | B1 |
6514286 | Leatherbury et al. | Feb 2003 | B1 |
6514514 | Atkinson et al. | Feb 2003 | B1 |
6540773 | Dong | Apr 2003 | B2 |
6541023 | Andre et al. | Apr 2003 | B1 |
6548077 | Gunasekaran | Apr 2003 | B1 |
6554855 | Dong | Apr 2003 | B1 |
6559119 | Burgess et al. | May 2003 | B1 |
6566345 | Miller et al. | May 2003 | B2 |
6575988 | Rousseau | Jun 2003 | B2 |
6576019 | Atala | Jun 2003 | B1 |
6596002 | Therin et al. | Jul 2003 | B2 |
6596304 | Bayon et al. | Jul 2003 | B1 |
6599323 | Melican et al. | Jul 2003 | B2 |
6599524 | Li et al. | Jul 2003 | B2 |
6599690 | Abraham et al. | Jul 2003 | B1 |
6610006 | Amid et al. | Aug 2003 | B1 |
6613348 | Jain | Sep 2003 | B1 |
6616685 | Rousseau | Sep 2003 | B2 |
6623963 | Muller et al. | Sep 2003 | B1 |
6630414 | Matsumoto | Oct 2003 | B1 |
6637437 | Hungerford et al. | Oct 2003 | B1 |
6638284 | Rousseau et al. | Oct 2003 | B1 |
6645226 | Jacobs et al. | Nov 2003 | B1 |
6652594 | Francis et al. | Nov 2003 | B2 |
6652595 | Nicolo | Nov 2003 | B1 |
6653450 | Berg et al. | Nov 2003 | B1 |
6656206 | Corcoran et al. | Dec 2003 | B2 |
6660280 | Allard et al. | Dec 2003 | B1 |
6669735 | Pelissier | Dec 2003 | B1 |
6670018 | Fujita et al. | Dec 2003 | B2 |
6682760 | Noff et al. | Jan 2004 | B2 |
6685714 | Rousseau | Feb 2004 | B2 |
6706684 | Bayon et al. | Mar 2004 | B1 |
6706690 | Reich et al. | Mar 2004 | B2 |
6712859 | Rousseau et al. | Mar 2004 | B2 |
6719795 | Cornwall et al. | Apr 2004 | B1 |
6723335 | Moehlenbruck et al. | Apr 2004 | B1 |
6726660 | Hessel et al. | Apr 2004 | B2 |
6730299 | Tayot et al. | May 2004 | B1 |
6736823 | Darois et al. | May 2004 | B2 |
6736854 | Vadurro et al. | May 2004 | B2 |
6737371 | Planck et al. | May 2004 | B1 |
6743435 | DeVore et al. | Jun 2004 | B2 |
6746458 | Cloud | Jun 2004 | B1 |
6752834 | Geistlich et al. | Jun 2004 | B2 |
6755868 | Rousseau | Jun 2004 | B2 |
6773723 | Spiro et al. | Aug 2004 | B1 |
6783554 | Amara et al. | Aug 2004 | B2 |
6790213 | Cherok et al. | Sep 2004 | B2 |
6790454 | Abdul Malak et al. | Sep 2004 | B1 |
6800082 | Rousseau | Oct 2004 | B2 |
6833408 | Sehl et al. | Dec 2004 | B2 |
6835336 | Watt | Dec 2004 | B2 |
6852330 | Bowman et al. | Feb 2005 | B2 |
6869938 | Schwartz et al. | Mar 2005 | B1 |
6872227 | Sump et al. | Mar 2005 | B2 |
6893653 | Abraham et al. | May 2005 | B2 |
6896904 | Spiro et al. | May 2005 | B2 |
6926723 | Mulhauser et al. | Aug 2005 | B1 |
6936276 | Spiro et al. | Aug 2005 | B2 |
6939562 | Spiro et al. | Sep 2005 | B2 |
6949625 | Tayot | Sep 2005 | B2 |
6966918 | Schuldt-Hempe et al. | Nov 2005 | B1 |
6971252 | Therin et al. | Dec 2005 | B2 |
6974679 | Andre et al. | Dec 2005 | B2 |
6974862 | Ringeisen et al. | Dec 2005 | B2 |
6977231 | Matsuda | Dec 2005 | B1 |
6984392 | Bechert et al. | Jan 2006 | B2 |
6988386 | Okawa et al. | Jan 2006 | B1 |
7011688 | Gryska et al. | Mar 2006 | B2 |
7021086 | Ory et al. | Apr 2006 | B2 |
7022358 | Eckmayer et al. | Apr 2006 | B2 |
7025063 | Snitkin et al. | Apr 2006 | B2 |
7041868 | Greene et al. | May 2006 | B2 |
7060103 | Carr, Jr. et al. | Jun 2006 | B2 |
RE39172 | Bayon et al. | Jul 2006 | E |
7070558 | Gellman et al. | Jul 2006 | B2 |
7087065 | Ulmsten et al. | Aug 2006 | B2 |
7094261 | Zotti et al. | Aug 2006 | B2 |
7098315 | Schaufler | Aug 2006 | B2 |
7101381 | Ford et al. | Sep 2006 | B2 |
7115220 | Dubson et al. | Oct 2006 | B2 |
7156804 | Nicolo | Jan 2007 | B2 |
7156858 | Schuldt-Hempe et al. | Jan 2007 | B2 |
7175852 | Simmoteit et al. | Feb 2007 | B2 |
7192604 | Brown et al. | Mar 2007 | B2 |
7207962 | Anand et al. | Apr 2007 | B2 |
7214765 | Ringeisen et al. | May 2007 | B2 |
7226611 | Yura et al. | Jun 2007 | B2 |
7229453 | Anderson et al. | Jun 2007 | B2 |
7252837 | Guo et al. | Aug 2007 | B2 |
7279177 | Looney et al. | Oct 2007 | B2 |
7331199 | Ory et al. | Feb 2008 | B2 |
7393319 | Merade et al. | Jul 2008 | B2 |
7556598 | Rao | Jul 2009 | B2 |
7594921 | Browning | Sep 2009 | B2 |
7614258 | Cherok et al. | Nov 2009 | B2 |
7615065 | Priewe et al. | Nov 2009 | B2 |
7662169 | Wittmann | Feb 2010 | B2 |
7670380 | Cauthen, III | Mar 2010 | B2 |
7682381 | Rakos et al. | Mar 2010 | B2 |
7709017 | Tayot | May 2010 | B2 |
7718556 | Matsuda et al. | May 2010 | B2 |
7732354 | Fricke et al. | Jun 2010 | B2 |
7785334 | Ford et al. | Aug 2010 | B2 |
7789888 | Bartee et al. | Sep 2010 | B2 |
7799767 | Lamberti et al. | Sep 2010 | B2 |
7806905 | Ford et al. | Oct 2010 | B2 |
7824420 | Eldridge et al. | Nov 2010 | B2 |
7828854 | Rousseau et al. | Nov 2010 | B2 |
7900484 | Cherok et al. | Mar 2011 | B2 |
7931695 | Ringeisen | Apr 2011 | B2 |
8052759 | Dupic et al. | Nov 2011 | B2 |
8079023 | Chen | Dec 2011 | B2 |
8100924 | Browning | Jan 2012 | B2 |
8123817 | Intoccia et al. | Feb 2012 | B2 |
8142515 | Therin et al. | Mar 2012 | B2 |
8157821 | Browning | Apr 2012 | B2 |
8157822 | Browning | Apr 2012 | B2 |
8182545 | Cherok et al. | May 2012 | B2 |
8197837 | Jamiolkowski et al. | Jun 2012 | B2 |
8206632 | Rousseau et al. | Jun 2012 | B2 |
8215310 | Browning | Jul 2012 | B2 |
8317872 | Adams | Nov 2012 | B2 |
8323675 | Greenawalt | Dec 2012 | B2 |
8343232 | Adzich et al. | Jan 2013 | B2 |
8366787 | Brown et al. | Feb 2013 | B2 |
8435307 | Paul | May 2013 | B2 |
8470355 | Skalla et al. | Jun 2013 | B2 |
8562633 | Cully et al. | Oct 2013 | B2 |
8574627 | Martakos et al. | Nov 2013 | B2 |
8709094 | Stad et al. | Apr 2014 | B2 |
8734471 | Deitch | May 2014 | B2 |
8753360 | Gleiman et al. | Jun 2014 | B2 |
8758800 | Stopek et al. | Jun 2014 | B2 |
8784294 | Goddard | Jul 2014 | B2 |
8814887 | Walther et al. | Aug 2014 | B2 |
8828092 | Toso et al. | Sep 2014 | B2 |
8834864 | Odar et al. | Sep 2014 | B2 |
8846060 | Archibald et al. | Sep 2014 | B2 |
8865215 | Ladet et al. | Oct 2014 | B2 |
8877233 | Obermiller et al. | Nov 2014 | B2 |
8911504 | Mathisen et al. | Dec 2014 | B2 |
8920370 | Sholev et al. | Dec 2014 | B2 |
8956373 | Ford et al. | Feb 2015 | B2 |
8962006 | Bayon et al. | Feb 2015 | B2 |
8968762 | Ladet et al. | Mar 2015 | B2 |
8979935 | Lozier et al. | Mar 2015 | B2 |
9034357 | Stopek | May 2015 | B2 |
9113993 | Lee | Aug 2015 | B2 |
9211175 | Stopek et al. | Dec 2015 | B2 |
9216075 | Bailly et al. | Dec 2015 | B2 |
20020064551 | Edwards | May 2002 | A1 |
20020087174 | Capello | Jul 2002 | A1 |
20020095218 | Carr et al. | Jul 2002 | A1 |
20030055211 | Roberts | Mar 2003 | A1 |
20030086975 | Ringeisen | May 2003 | A1 |
20030091851 | Khor | May 2003 | A1 |
20030114937 | Leatherbury et al. | Jun 2003 | A1 |
20030133967 | Ruszczak et al. | Jul 2003 | A1 |
20030225355 | Butler | Dec 2003 | A1 |
20040034373 | Schuldt-Hempe et al. | Feb 2004 | A1 |
20040054376 | Ory et al. | Mar 2004 | A1 |
20040058013 | Taylor | Mar 2004 | A1 |
20040059356 | Gingras | Mar 2004 | A1 |
20040101546 | Gorman et al. | May 2004 | A1 |
20040243043 | McCarthy | Dec 2004 | A1 |
20050002893 | Goldmann | Jan 2005 | A1 |
20050021058 | Negro | Jan 2005 | A1 |
20050085924 | Darois et al. | Apr 2005 | A1 |
20050113849 | Popadiuk et al. | May 2005 | A1 |
20050137512 | Campbell et al. | Jun 2005 | A1 |
20050142161 | Freeman et al. | Jun 2005 | A1 |
20050148963 | Brennan | Jul 2005 | A1 |
20050175659 | Macomber et al. | Aug 2005 | A1 |
20050232979 | Shoshan | Oct 2005 | A1 |
20050267521 | Forsberg | Dec 2005 | A1 |
20050288691 | Leiboff | Dec 2005 | A1 |
20060116696 | Odermatt et al. | Jun 2006 | A1 |
20060135921 | Wiercinski et al. | Jun 2006 | A1 |
20060147501 | Hillas et al. | Jul 2006 | A1 |
20060159732 | Cullen | Jul 2006 | A1 |
20060172000 | Cullen | Aug 2006 | A1 |
20060216320 | Kitazono et al. | Sep 2006 | A1 |
20060252981 | Matsuda et al. | Nov 2006 | A1 |
20060253203 | Alvarado | Nov 2006 | A1 |
20060282103 | Fricke et al. | Dec 2006 | A1 |
20070032805 | Therin | Feb 2007 | A1 |
20070088391 | McAlexander et al. | Apr 2007 | A1 |
20070129736 | Solecki | Jun 2007 | A1 |
20070198040 | Buevich et al. | Aug 2007 | A1 |
20070237811 | Scherr | Oct 2007 | A1 |
20070299538 | Roeber | Dec 2007 | A1 |
20080091276 | Deusch et al. | Apr 2008 | A1 |
20080109017 | Herweck et al. | May 2008 | A1 |
20080113001 | Herweck et al. | May 2008 | A1 |
20080172071 | Barker | Jul 2008 | A1 |
20080181936 | Filatov | Jul 2008 | A1 |
20080255593 | St-Germain | Oct 2008 | A1 |
20090035341 | Wagener et al. | Feb 2009 | A1 |
20090036996 | Roeber | Feb 2009 | A1 |
20090068250 | Gravagna et al. | Mar 2009 | A1 |
20090105526 | Piroli Torelli et al. | Apr 2009 | A1 |
20090163936 | Yang et al. | Jun 2009 | A1 |
20090187197 | Roeber et al. | Jul 2009 | A1 |
20090192530 | Adzich et al. | Jul 2009 | A1 |
20090204129 | Fronio | Aug 2009 | A1 |
20090216338 | Gingras et al. | Aug 2009 | A1 |
20090270999 | Brown | Oct 2009 | A1 |
20090281558 | Li | Nov 2009 | A1 |
20090318752 | Evans et al. | Dec 2009 | A1 |
20100104608 | Abuzaina et al. | Apr 2010 | A1 |
20100318108 | Datta et al. | Dec 2010 | A1 |
20110015760 | Kullas | Jan 2011 | A1 |
20110144667 | Horton et al. | Jun 2011 | A1 |
20110190795 | Hotter et al. | Aug 2011 | A1 |
20110238094 | Thomas et al. | Sep 2011 | A1 |
20110251699 | Ladet | Oct 2011 | A1 |
20110257666 | Ladet et al. | Oct 2011 | A1 |
20110311632 | Roorda | Dec 2011 | A1 |
20120016388 | Houard et al. | Jan 2012 | A1 |
20120022242 | Domard | Jan 2012 | A1 |
20120029537 | Mortarino | Feb 2012 | A1 |
20120065727 | Reneker et al. | Mar 2012 | A1 |
20120082712 | Stopek et al. | Apr 2012 | A1 |
20120093686 | Kirsch | Apr 2012 | A1 |
20120116425 | Intoccia et al. | May 2012 | A1 |
20120150204 | Mortarino et al. | Jun 2012 | A1 |
20120165937 | Montanari et al. | Jun 2012 | A1 |
20120179175 | Hammell | Jul 2012 | A1 |
20120179176 | Wilson et al. | Jul 2012 | A1 |
20120197415 | Montanari et al. | Aug 2012 | A1 |
20130287836 | Ingber | Oct 2013 | A1 |
20140044861 | Boey et al. | Feb 2014 | A1 |
20140364684 | Lecuivre | Dec 2014 | A1 |
Number | Date | Country |
---|---|---|
1317836 | May 1993 | CA |
201879864 | Jun 2011 | CN |
19544162 | Apr 1997 | DE |
19718903 | Dec 1997 | DE |
19751733 | Dec 1998 | DE |
19832634 | Jan 2000 | DE |
10019604 | Oct 2001 | DE |
10120942 | Oct 2001 | DE |
10043396 | Jun 2002 | DE |
0194192 | Sep 1986 | EP |
0248544 | Dec 1987 | EP |
0263360 | Apr 1988 | EP |
0276890 | Aug 1988 | EP |
0372969 | Jun 1990 | EP |
0531742 | Mar 1993 | EP |
544485 | Jun 1993 | EP |
0552576 | Jul 1993 | EP |
0611561 | Aug 1994 | EP |
614650 | Sep 1994 | EP |
0621014 | Oct 1994 | EP |
0625891 | Nov 1994 | EP |
0637452 | Feb 1995 | EP |
0664132 | Jul 1995 | EP |
0705878 | Apr 1996 | EP |
0719527 | Jul 1996 | EP |
0774240 | May 1997 | EP |
0797962 | Oct 1997 | EP |
0800791 | Oct 1997 | EP |
827724 | Mar 1998 | EP |
0836838 | Apr 1998 | EP |
0847727 | Jun 1998 | EP |
0876808 | Nov 1998 | EP |
0895762 | Feb 1999 | EP |
898944 | Mar 1999 | EP |
1017415 | Jul 2000 | EP |
1036545 | Sep 2000 | EP |
1052319 | Nov 2000 | EP |
1055757 | Nov 2000 | EP |
1090590 | Apr 2001 | EP |
1 216 717 | Jun 2002 | EP |
1 216 718 | Jun 2002 | EP |
0693523 | Nov 2002 | EP |
1315468 | Jun 2003 | EP |
1382728 | Jan 2004 | EP |
1484070 | Dec 2004 | EP |
1561480 | Aug 2005 | EP |
1645232 | Apr 2006 | EP |
1674048 | Jun 2006 | EP |
1691606 | Aug 2006 | EP |
1782848 | May 2007 | EP |
1 952 828 | Aug 2008 | EP |
2229918 | Sep 2010 | EP |
2244853 | Apr 1975 | FR |
2257262 | Aug 1975 | FR |
2 308 349 | Nov 1976 | FR |
2453231 | Oct 1980 | FR |
2612392 | Sep 1988 | FR |
2715309 | Jul 1995 | FR |
2715405 | Jul 1995 | FR |
2 724 563 | Mar 1996 | FR |
2730406 | Aug 1996 | FR |
2744906 | Aug 1997 | FR |
2766698 | Feb 1999 | FR |
2771622 | Jun 1999 | FR |
2773057 | Jul 1999 | FR |
2774277 | Aug 1999 | FR |
2779937 | Dec 1999 | FR |
2859624 | Mar 2005 | FR |
2863277 | Jun 2005 | FR |
2876020 | Apr 2006 | FR |
2884706 | Oct 2006 | FR |
2929834 | Oct 2009 | FR |
2953709 | Jun 2011 | FR |
1174814 | Dec 1969 | GB |
2 051 153 | Jan 1981 | GB |
2306110 | Apr 1997 | GB |
H0332677 | Feb 1991 | JP |
H05237128 | Sep 1993 | JP |
H09137380 | May 1997 | JP |
H11146888 | Jun 1999 | JP |
2008538300 | Oct 2008 | JP |
2011078767 | Apr 2011 | JP |
8902445 | Mar 1989 | WO |
8908467 | Sep 1989 | WO |
9012551 | Nov 1990 | WO |
9206639 | Apr 1992 | WO |
9220349 | Nov 1992 | WO |
9311805 | Jun 1993 | WO |
9310731 | Jun 1993 | WO |
9318174 | Sep 1993 | WO |
9417747 | Aug 1994 | WO |
9507666 | Mar 1995 | WO |
9518638 | Jul 1995 | WO |
9532687 | Dec 1995 | WO |
9603091 | Feb 1996 | WO |
9608277 | Mar 1996 | WO |
9609795 | Apr 1996 | WO |
9614805 | May 1996 | WO |
9641588 | Dec 1996 | WO |
9735533 | Oct 1997 | WO |
9835632 | Aug 1998 | WO |
9849967 | Nov 1998 | WO |
9905990 | Feb 1999 | WO |
9906079 | Feb 1999 | WO |
9906080 | Feb 1999 | WO |
9951163 | Oct 1999 | WO |
0016821 | Mar 2000 | WO |
0067663 | Nov 2000 | WO |
0115625 | Mar 2001 | WO |
0180773 | Nov 2001 | WO |
0181667 | Nov 2001 | WO |
0207648 | Jan 2002 | WO |
0217853 | Mar 2002 | WO |
02078568 | Oct 2002 | WO |
03002168 | Jan 2003 | WO |
2004004600 | Jan 2004 | WO |
2004071349 | Aug 2004 | WO |
2004078120 | Sep 2004 | WO |
2004103212 | Dec 2004 | WO |
2005011280 | Feb 2005 | WO |
2005013863 | Feb 2005 | WO |
2005018698 | Mar 2005 | WO |
2005048708 | Jun 2005 | WO |
2005105172 | Nov 2005 | WO |
2006018552 | Feb 2006 | WO |
2006023414 | Mar 2006 | WO |
2007048099 | Apr 2007 | WO |
2009031035 | Mar 2009 | WO |
2009071998 | Jun 2009 | WO |
2010043978 | Apr 2010 | WO |
2011026987 | Mar 2011 | WO |
2011038740 | Apr 2011 | WO |
WO 2011066471 | Jun 2011 | WO |
Entry |
---|
Australian Office Action issued Apr. 8, 2016 in corresponding Australian Patent Application No. 2013322689, 3 pages. |
Ellouali, M. et al., “Antitumor Activity of Low Molecular Weight Fucans Extracted from Brown Seaweed Ascophyllum Nodosum,” Anticancer Res., Nov.-Dec. 1993, pp. 2011-2020, 12 (6A). |
Malette, W. G. et al., “Chitosan, A New Hemostatic,” Ann Th. Surg., Jul. 1983, pp. 55-58, 36. |
Langenbech, M. R. et al., “Comparison of biomaterials in the early postoperative period,” Surg Endosc., May 2003, pp. 1105-1109, 17 (7). |
Bracco, P. et al., “Comparison of polypropylene and polyethylene terephthalate (Dacron) meshes for abdominal wall hernia repair: A chemical and morphological study,” Hernia, 2005, pp. 51-55, 9 (1), published online Sep. 2004. |
Klinge, U. et al., “Foreign Body Reaction to Meshes Used for the Repair of Abdominal Wall Hernias,” Eur J. Surg, Sep. 1999, pp. 665-673, 165. |
Logeart, D. et al., “Fucans, sulfated polysaccharides extracted from brown seaweeds, inhibit vascular smooth muscle cell proliferation. II. Degradation and molecular weight effect,” Eur. J. Cell. Biol., Dec. 1997, pp. 385-390, 74(4). |
Haneji, K. et al., “Fucoidan extracted from Cladosiphon Okamuranus Tokida Induces Apoptosis of Human T-cell Leukemia Virus Type 1-Infected T-Cell Lines and Primary Adult T-Cell Leukemia Cells,” Nutrition and Cancer, 2005, pp. 189-201, 52(2), published online Nov. 2009. |
Junge, K. et al., “Functional and Morphologic Properties of a Modified Mesh for Inguinal Hernia Repair,” World J. Surg., Sep. 2002, pp. 1472-1480, 26. |
Klinge, U. et al., “Functional and Morphological Evaluation of a Low-Weight, Monofilament Polypropylene Mesh for Hernia Repair,” J. Biomed. Mater. Res., Jan. 2002, pp. 129-136, 63. |
Welty, G. et al., “Functional impairment and complaints following incisional hernia repair with different polypropylene meshes,” Hernia, Aug. 2001; pp. 142-147, 5. |
Varum, K. et al., “In vitro degradation rates of partially N-acetylated chitosans in human serum,” Carbohydrate Research, Mar. 1997, pp. 99-101, 299. |
Haroun-Bouhedja, F. et al., “In Vitro Effects of Fucans on MDA-MB231 Tumor Cell Adhesion and Invasion,” Anticancer Res., Jul.-Aug. 2002, pp. 2285-2292, 22(4). |
Scheidbach, H. et al., “In vivo studies comparing the biocompatibility of various polypropylene meshes and their handling properties during endoscopic total extraperitoneal (TEP) patchplasty: An experimental study in pigs,” Surg. Endosc., Feb. 2004, pp. 211-220,18(2). |
Blondin, C. et al., “Inhibition of Complement Activation by Natural Sulfated Polysaccharides (Fucans) from Brown Seaweed,” Molecular Immuol., Mar. 1994, pp. 247-253, 31(4). |
Zvyagintseva, T. et al., “Inhibition of complement activation by water-soluble polysaccharides of some far-eastern brown seaweeds,” Comparative Biochem and Physiol, Jul. 2000, pp. 209-215,126(3). |
Rosen, M. et al., “Laparoscopic component separation in the single-stage treatment of infected abdominal wall prosthetic removal,” Hernia, 2007, pp. 435-440, 11, published online Jul. 2007. |
Amid, P., “Lichtenstein tension-free hernioplasty: Its inception, evolution, and principles,” Hernia, 2004; pp. 1-7, 8, published online Sep. 2003. |
Boisson-Vidal, C. et al., “Neoangiogenesis Induced by Progenitor Endothelial Cells: Effect of Fucoidan From Marine Algae,” Cardiovascular & Hematological Agents in Medicinal Chem., Jan. 2007, pp. 67-77, 5(1). |
O'Dwyer, P. et al., “Randomized clinical trial assessing impact of a lightweight or heavyweight mesh on chronic pain after inguinal hernia repair,” Br. J. Surg., Feb. 2005, pp. 166-170, 92(2). |
Muzzarelli, R. et al., “Reconstruction of parodontal tissue with chitosan,” Biomaterials, Nov. 1989, pp. 598-604, 10. |
Haroun-Bouhedja, F. et al., “Relationship between sulfate groups and biological activities of fucans,” Thrombosis Res., Dec. 2000, pp. 453-459, 100(5). |
Blondin, C. et al., “Relationships between chemical characteristics and anticomplementary activity of fucans,” Biomaterials, Mar. 1996, pp. 597-603, 17(6). |
Strand, S. et al., “Screening of Chitosans and Conditions for Bacterial Flocculation,” Biomacromolecules, Mar. 2001, 126-133, 2. |
Kanabar, V. et al., “Some structural determinants of the antiproliferative effect of heparin-like molecules on human airway smooth muscle,” Br. J. Pharmacol., Oct. 2005, pp. 370-777, 146(3). |
Hirano, S. et al., “The blood biocompatibility of chitosan and N-acylchitosans,” J. Biomed. Mater. Res., Apr. 1985, 413-417, 19. |
Rao, B. et al., “Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential,” J. Biomed. Mater. Res., Jan. 1997, pp. 21-28, 34. |
Prokop, A. et al., “Water Soluble Polymers for Immunoisolation I: Complex Coacevation and Cytotoxicity,” Advances in Polymer Science, Jul. 1998, pp. 1-51, 136. |
Collins, R. et al., “Use of collagen film as a dural substitute: Preliminary animal studies,” Journal of Biomedical Materials Research, Feb. 1991, pp. 267-276, vol. 25. |
Preliminary Search Report from French Patent Office dated Dec. 20, 2006, 3 pages. |
Lamarque, G. et al, “New Route of Deacetylation of alpha- and beta-Chitins by Means of Freeze-Pump Out-Thaw Cycles” Biomacromolecules, May-Jun. 2005, pp. 1380-1388, 6. |
Lamarque, G. et al., Comparative Study of the First Heterogeneous Deacetylation of alpha- and beta-Chitins in a Multistep Process Biomacromolecules May-Jun. 2004, 992-1001, 5. |
Lamarque, G. et al., “Comparative Study of the Second and Third Heterogeneous Deacetylations of alpha- and beta-Chitins in a Multistep Process” Biomacromolecules, Sep.-Oct. 5, 2004, pp. 1899-1907, 5. |
Tolaimate, A., et al. “Contribution to the preparation of chitins and chitosans with controlled physico-chemical properties.” Polymer, Dec. 2003, pp. 7939-7952, 44 (26). |
International Search Report for PCT/EP13/069957 date of completion is Feb. 25, 2014 (2 pages). |
European Office Action issued Nov. 4, 2016 in corresponding European Patent Application No. 13766967.7, 5 pages. |
Number | Date | Country | |
---|---|---|---|
20150202342 A1 | Jul 2015 | US |